140 related articles for article (PubMed ID: 35197273)
1. False-Positive
Parghane RV; Basu S
J Nucl Med Technol; 2023 Mar; 51(1):73-74. PubMed ID: 35197273
[No Abstract] [Full Text] [Related]
2. Comparison of
Yu HN; Liu L; Chen QS; He Q; Li YS; Wang Y; Gao S
Orthop Surg; 2021 May; 13(3):791-798. PubMed ID: 33709632
[TBL] [Abstract][Full Text] [Related]
3.
El-Maouche D; Sadowski SM; Papadakis GZ; Guthrie L; Cottle-Delisle C; Merkel R; Millo C; Chen CC; Kebebew E; Collins MT
J Clin Endocrinol Metab; 2016 Oct; 101(10):3575-3581. PubMed ID: 27533306
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor imaging with [
Zhao L; Pang Y; Wang Y; Chen J; Zhuang Y; Zhang J; Zhao L; Sun L; Wu H; Chen X; Lin Q; Chen H
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1360-1373. PubMed ID: 34665275
[TBL] [Abstract][Full Text] [Related]
5. 68Ga DOTATATE PET/CT is an Accurate Imaging Modality in the Detection of Culprit Tumors Causing Osteomalacia.
Zhang J; Zhu Z; Zhong D; Dang Y; Xing H; Du Y; Jing H; Qiao Z; Xing X; Zhuang H; Li F
Clin Nucl Med; 2015 Aug; 40(8):642-6. PubMed ID: 26053726
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic osteomalacia: role of Ga-68 DOTANOC PET/CT scan in identifying the culprit lesion and its management.
Singh D; Chopra A; Ravina M; Kongara S; Bhatia E; Kumar N; Gupta S; Yadav S; Dabadghao P; Yadav R; Dube V; Kumar U; Dixit M; Gambhir S
Br J Radiol; 2017 Apr; 90(1072):20160811. PubMed ID: 28181822
[TBL] [Abstract][Full Text] [Related]
7. Increased Activity Due to Fractures Does Not Significantly Affect the Accuracy of 68Ga-DOTATATE PET/CT in the Detection of Culprit Tumor in the Evaluation of Tumor-Induced Osteomalacia.
Ding J; Hu G; Wang L; Li F; Huo L
Clin Nucl Med; 2018 Dec; 43(12):880-886. PubMed ID: 30273206
[TBL] [Abstract][Full Text] [Related]
8. Value of the
Fastrez M; Artigas C; Sirtaine N; Wimana Z; Caillet M; Rozenberg S; Flamen P
Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():69-74. PubMed ID: 28342392
[TBL] [Abstract][Full Text] [Related]
9. Utility of 18F-AlF-NOTA-Octreotide PET/CT in the Localization of Tumor-Induced Osteomalacia.
Long T; Hou J; Yang N; Zhou M; Li Y; Li J; Tang Y; Chen D; Hu S
J Clin Endocrinol Metab; 2021 Sep; 106(10):e4202-e4209. PubMed ID: 33864458
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of
Lee DY; Lee SH; Kim BJ; Kim W; Yoon PW; Lee SJ; Oh SJ; Koh JM; Ryu JS
Sci Rep; 2021 Jan; 11(1):1819. PubMed ID: 33469091
[TBL] [Abstract][Full Text] [Related]
11. Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT.
Clifton-Bligh RJ; Hofman MS; Duncan E; Sim IeW; Darnell D; Clarkson A; Wong T; Walsh JP; Gill AJ; Ebeling PR; Hicks RJ
J Clin Endocrinol Metab; 2013 Feb; 98(2):687-94. PubMed ID: 23295468
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia.
Agrawal K; Bhadada S; Mittal BR; Shukla J; Sood A; Bhattacharya A; Bhansali A
Clin Nucl Med; 2015 Jan; 40(1):e6-e10. PubMed ID: 24999675
[TBL] [Abstract][Full Text] [Related]
14. Head-to-Head Comparison of
Zhu W; Cheng Y; Wang X; Yao S; Bai C; Zhao H; Jia R; Xu J; Huo L
J Nucl Med; 2020 Jun; 61(6):897-903. PubMed ID: 31676731
[No Abstract] [Full Text] [Related]
15. Diagnostic performance of
Kato A; Nakamoto Y; Ishimori T; Hayakawa N; Ueda M; Temma T; Sano K; Shimizu Y; Saga T; Togashi K
Ann Nucl Med; 2021 Mar; 35(3):397-405. PubMed ID: 33582980
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic efficiency of
He Q; Zhang B; Zhang L; Chen Z; Shi X; Yi C; Wang X; Zhang X
Eur Radiol; 2021 Apr; 31(4):2414-2421. PubMed ID: 33021702
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance and impact on patient management of
Paquet M; Gauthé M; Zhang Yin J; Nataf V; Bélissant O; Orcel P; Roux C; Talbot JN; Montravers F
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1710-1720. PubMed ID: 29532101
[TBL] [Abstract][Full Text] [Related]
18. Optimizing Somatostatin Receptor Imaging in Patients With Neuroendocrine Tumors: The Impact of 99mTc-HYNICTOC SPECT/SPECT/CT Versus 68Ga-DOTATATE PET/CT Upon Clinical Management.
Kunikowska J; Lewington V; Krolicki L
Clin Nucl Med; 2017 Dec; 42(12):905-911. PubMed ID: 29076910
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation.
Jois B; Asopa R; Basu S
Clin Nucl Med; 2014 Jun; 39(6):505-10. PubMed ID: 24662668
[TBL] [Abstract][Full Text] [Related]
20. Sphenoid sinus is a rare site for tumor-induced osteomalacia: A case report and literature review.
Wang F; He W; Ma D; Xu W; Xie J; Yuan G
Front Endocrinol (Lausanne); 2023; 14():1116793. PubMed ID: 37033241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
